Logo
C

CellFE - Cell Fluidics Engineering

18 employees

CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Gene editing
Crispr/Cas9
Biotech
Viral vectors
Health Care
High throughput technology
Gene therapies
Bioprocessing
Plasmid
Medical devices
Cell therapies
mRNA
Microfluidics
Cell engineering
Cancer therapies

Date founded

2018

Funding rounds raised

Total raised

$22M

from 12 investors over 12 rounds

C

CellFE - Cell Fluidics Engineering raised $22M on September 27, 2023

Investors: GreatPoint Ventures, Riverine Ventures, Khosla Ventures, Embark Ventures, M Ventures, Elm Street Ventures and Cota Capital

C

CellFE - Cell Fluidics Engineering raised $4.8M on January 16, 2020

Investors: Cota Capital, Creative Destruction Lab, Elm Street Ventures and Embark Ventures

C

CellFE - Cell Fluidics Engineering raised undisclosed on September 1, 2018

Investors: Berkeley SkyDeck

FAQ